You Cheng Khng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
You Cheng Khng has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Gareth T. W. Law
Radiochemistry Unit, Department of Chemistry, Faculty of Science, University of Helsinki, A.I. Virtasen aukio 1, P.O. Box 55, Helsinki, FI-00014, Finland
3 shared publications - Gianni F. Vettese
The University of Helsinki
3 shared publications - Mirkka Sarparanta
University of Helsinki
3 shared publications Anna M. Psyrillou
The University of Helsinki
1 shared publication- Anu J. Airaksinen
Turku PET Centre, University of Turku, Kiinamyllynkatu 4-8, Turku FI-20520, Finland
1 shared publication - Brian M. Zeglis
The City University of New York
1 shared publication
Latest Publications
- Open Access
- 25 September 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (39) , 59601-59612
Toxicity, Cellular Uptake, and Intracellular Fate of Particulate and Dissolved Uranium in Murine Lung-Relevant Cell Models
Uranium dioxide (UO2) particles pose an inhalation hazard in occupational and environmental exposure scenarios, yet their cellular interactions and toxicological behavior remain poorly defined. This study investigated the dissolution behavior and colloid-forming potential of UO2 in cell culture media, and compared the cytotoxicity, inflammatory response, and intracellular fate with those from equivalent aqueous uranium (U(aq)) exposures in murine RAW264.7 macrophages and Mlg2908 lung fibroblasts in vitro. In cell culture media, UO2 exhibited low solubility and limited colloid formation (∼5% colloidal), whereas U(aq) showed a higher proportion of colloid species (∼21%). In cellular exposure studies, particulate UO2 was generally more toxic than U(aq) across all concentrations (12–120 μg/mL; 50–500 μM) and exposure durations (6–48 h). A significant inflammatory response was observed only in macrophages exposed to 60 μg/mL of UO2. Uranium was predominantly recovered in the intracellular fraction of cells exposed to UO2 (68–79% of added U), whereas U(aq) exposures remained largely extracellular (∼1% intracellular fraction of added U). TEM showed that UO2 particles were localized within membrane-bound vesicular structures. HR-TEM and elemental analyses showed that internalized UO2 particles largely retained their chemical integrity after 24 h. Overall, these findings demonstrate that particulate UO2 is more toxic than U(aq), and its toxicity in vitro reflects cell-type-specific responses and particle stability following internalization, underscoring the importance of U speciation and physico-chemical form in inhalation health risk assessment.
- 25 September 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (39) , 59601-59612
Open AccessToxicity, Cellular Uptake, and Intracellular Fate of Particulate and Dissolved Uranium in Murine Lung-Relevant Cell Models
Uranium dioxide (UO2) particles pose an inhalation hazard in occupational and environmental exposure scenarios, yet their cellular interactions and toxicological behavior remain poorly defined. This study investigated the dissolution behavior and colloid-forming potential of UO2 in cell culture media, and compared the cytotoxicity, inflammatory response, and intracellular fate with those from equivalent aqueous uranium (U(aq)) exposures in murine RAW264.7 macrophages and Mlg2908 lung fibroblasts in vitro. In cell culture media, UO2 exhibited low solubility and limited colloid formation (∼5% colloidal), whereas U(aq) showed a higher proportion of colloid species (∼21%). In cellular exposure studies, particulate UO2 was generally more toxic than U(aq) across all concentrations (12–120 μg/mL; 50–500 μM) and exposure durations (6–48 h). A significant inflammatory response was observed only in macrophages exposed to 60 μg/mL of UO2. Uranium was predominantly recovered in the intracellular fraction of cells exposed to UO2 (68–79% of added U), whereas U(aq) exposures remained largely extracellular (∼1% intracellular fraction of added U). TEM showed that UO2 particles were localized within membrane-bound vesicular structures. HR-TEM and elemental analyses showed that internalized UO2 particles largely retained their chemical integrity after 24 h. Overall, these findings demonstrate that particulate UO2 is more toxic than U(aq), and its toxicity in vitro reflects cell-type-specific responses and particle stability following internalization, underscoring the importance of U speciation and physico-chemical form in inhalation health risk assessment.
- Open Access
- 14 October 2025
- Published by Springer Nature in Journal of Radioanalytical and Nuclear Chemistry
- Vol. 334 (10) , 7167-7177
Physicochemical evolution of a geopolymer wasteform for immobilizing thermally treated spent ion exchange resins: structural changes and cesium leachability
Thermally-treated spent ion-exchange resins (OIXRs) were immobilized by mixing 1 wt% ash with a metakaolin geopolymer. Stable 133 Cs simulated 137 Cs. Year-long semi-dynamic leaching experiments at pH 12.5 monitored changes in pH, conductivity and dissolved ions. Na, Al, Si were rapidly released into solution and 32% of Cs leached within 28 days. Ca uptake dominated, driving Na-Ca exchange and progressive N–A–S–H to C–A–S–H transformation. XRD, FE-SEM–EDX and 27 Al/ 29 Si MAS-NMR showed depolymerization, Ca-rich precipitates and loss of tetrahedral Al. Despite 59% Cs loss after 1 year, results demonstrate the matrix’s long-term chemical evolution and its promise as a sustainable OIXR wasteform.
- 14 October 2025
- Published by Springer Nature in Journal of Radioanalytical and Nuclear Chemistry
- Vol. 334 (10) , 7167-7177
Open AccessPhysicochemical evolution of a geopolymer wasteform for immobilizing thermally treated spent ion exchange resins: structural changes and cesium leachability
Thermally-treated spent ion-exchange resins (OIXRs) were immobilized by mixing 1 wt% ash with a metakaolin geopolymer. Stable 133 Cs simulated 137 Cs. Year-long semi-dynamic leaching experiments at pH 12.5 monitored changes in pH, conductivity and dissolved ions. Na, Al, Si were rapidly released into solution and 32% of Cs leached within 28 days. Ca uptake dominated, driving Na-Ca exchange and progressive N–A–S–H to C–A–S–H transformation. XRD, FE-SEM–EDX and 27 Al/ 29 Si MAS-NMR showed depolymerization, Ca-rich precipitates and loss of tetrahedral Al. Despite 59% Cs loss after 1 year, results demonstrate the matrix’s long-term chemical evolution and its promise as a sustainable OIXR wasteform.
- Open Access
- 25 August 2025
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 497, 139670
Chemical alteration of UO2 micro-particles in model lung systems
- 25 August 2025
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 497, 139670
Open AccessChemical alteration of UO2 micro-particles in model lung systems
- Open Access
A Theranostic Cellulose Nanocrystal‐Based Drug Delivery System with Enhanced Retention in Pulmonary Metastasis of Melanoma
Metastatic melanoma can be difficult to detect until at the advanced state that decreases the survival rate of patients. Several FDA‐approved BRAF inhibitors have been used for treatment of metastatic melanoma, but overall therapeutic efficacy has been limited. Lutetium‐177 (177Lu) enables simultaneous tracking of tracer accumulation with single‐photon emission computed tomography and radiotherapy. Therefore, the codelivery of 177Lu alongside chemotherapeutic agents using nanoparticles (NPs) might improve the therapeutic outcome in metastatic melanoma. Cellulose nanocrystals (CNC NPs) can particularly deliver payloads to lung capillaries in vivo. Herein, 177Lu‐labeled CNC NPs loaded with vemurafenib ([177Lu]Lu‐CNC‐V NPs) is developed and the therapeutic effect in BRAF V600E mutation‐harboring YUMM1.G1 murine model of lung metastatic melanoma is investigated. The [177Lu]Lu‐CNC‐V NPs demonstrate favorable radiolabel stability, drug release profile, cellular uptake, and cell growth inhibition in vitro. In vivo biodistribution reveals significant retention of the [177Lu]Lu‐CNC‐V NPs in the lung, liver, and spleen. Ultimately, the median survival time of animals is doubly increased after treatment with [177Lu]Lu‐CNC‐V NPs compared to control groups. The enhanced therapeutic efficacy of [177Lu]Lu‐CNC‐V NPs in the lung metastatic melanoma animal model provides convincing evidence for the potential of clinical translation for theranostic CNC NP‐based drug delivery systems after intravenous administration.
Open AccessA Theranostic Cellulose Nanocrystal‐Based Drug Delivery System with Enhanced Retention in Pulmonary Metastasis of Melanoma
Metastatic melanoma can be difficult to detect until at the advanced state that decreases the survival rate of patients. Several FDA‐approved BRAF inhibitors have been used for treatment of metastatic melanoma, but overall therapeutic efficacy has been limited. Lutetium‐177 (177Lu) enables simultaneous tracking of tracer accumulation with single‐photon emission computed tomography and radiotherapy. Therefore, the codelivery of 177Lu alongside chemotherapeutic agents using nanoparticles (NPs) might improve the therapeutic outcome in metastatic melanoma. Cellulose nanocrystals (CNC NPs) can particularly deliver payloads to lung capillaries in vivo. Herein, 177Lu‐labeled CNC NPs loaded with vemurafenib ([177Lu]Lu‐CNC‐V NPs) is developed and the therapeutic effect in BRAF V600E mutation‐harboring YUMM1.G1 murine model of lung metastatic melanoma is investigated. The [177Lu]Lu‐CNC‐V NPs demonstrate favorable radiolabel stability, drug release profile, cellular uptake, and cell growth inhibition in vitro. In vivo biodistribution reveals significant retention of the [177Lu]Lu‐CNC‐V NPs in the lung, liver, and spleen. Ultimately, the median survival time of animals is doubly increased after treatment with [177Lu]Lu‐CNC‐V NPs compared to control groups. The enhanced therapeutic efficacy of [177Lu]Lu‐CNC‐V NPs in the lung metastatic melanoma animal model provides convincing evidence for the potential of clinical translation for theranostic CNC NP‐based drug delivery systems after intravenous administration.